Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.48
—
Mkt Cap $599.82M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$6.68
Range $1.00 – $18.00
Implied Upside
+92.2%
Consensus $6.68 vs current $3.48